Abstract
Background
Neonatal hypoglycemia can impair neurodevelopment. Timely glucose screening, aligned with AAP guidelines, may enable prompt detection of hypoglycemia.
Methods
This initiative, conducted from November 2021 to April 2023, aimed to improve the timing of screening without negatively impacting breastfeeding. Key drivers included timely recognition of at-risk status and improved adherence to the institutional protocol.
Results
Overall, 823 infants were screened. Mean age at initial glucose screening decreased by 37%, from 175 to 111 min (p < 0.001). Median (IQR) age at hypoglycemia detection reduced from 133 (107–180) to 101 (81–118) minutes (p < 0.001). Late-detected hypoglycemia episodes (detected >2 h of age) among affected infants decreased from 30 to 0% (p = 0.06). Exclusive breastfeeding and NICU transfer rates for hypoglycemia remained stable.
Conclusions
Early recognition of risk factors, staff education, and improved team handoffs can improve timing of initial hypoglycemia screening without impacting breastfeeding or increasing maternal-infant separation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout



Similar content being viewed by others
References
Committee on Fetus and Newborn, Adamkin DH. Postnatal glucose homeostasis in late-preterm and term infants. Pediatrics. 2011;127:575–9.
Harding JE, Harris DL, Hegarty JE, Alsweiler JM, McKinlay CJ. An emerging evidence base for the management of neonatal hypoglycaemia [published correction appears in Early Hum Dev. Early Hum Dev. 2017;104:51–56. https://doi.org/10.1016/j.earlhumdev.2017.03.005.
Harding JE, Alsweiler JM, Edwards TE, McKinlay CJ. Neonatal hypoglycaemia. BMJ Med. 2024;3:e000544.
Adamkin DH. Neonatal hypoglycemia. Semin Fetal Neonatal Med. 2017;22:36–41.
Roeper M, Hoermann H, Körner LM, Sobottka M, Mayatepek E, Kummer S, et al. Transitional neonatal hypoglycemia and adverse neurodevelopment in midchildhood. JAMA Netw Open. 2024;7:e243683.
Kaiser JR, Bai S, Gibson N, Holland G, Lin TM, Swearingen CJ, et al. Association between transient newborn hypoglycemia and fourth-grade achievement test proficiency: a population-based study. JAMA Pediatr. 2015;169:913–21.
De Rose DU, Perri A, Maggio L, Salvatori G, Dotta A, Vento G, et al. Neonatal hypoglycemia and neurodevelopmental outcomes: yesterday, today, tomorrow. Eur J Pediatr. 2024;183:1113–9.
Ward Platt M, Deshpande S. Metabolic adaptation at birth. Semin Fetal Neonatal Med. 2005;10:341–50.
Hay WW Jr, Raju TN, Higgins RD, Kalhan SC, Devaskar SU. Knowledge gaps and research needs for understanding and treating neonatal hypoglycemia: workshop report from Eunice Kennedy Shriver National Institute of Child Health and Human Development. J Pediatr. 2009;155:612–7.
O’Brien M, Gilchrist C, Sadler L, Hegarty JE, Alsweiler JM. Infants eligible for neonatal hypoglycemia screening: a systematic review. JAMA Pediatr. 2023;177:1187–96.
Wei X, Franke N, Alsweiler JM, Brown GTL, Gamble GD, McNeill A, et al. Neonatal hypoglycemia and neurocognitive function at school age: a prospective cohort study. J Pediatr. 2024;272:114119.
McKinlay CJD, Alsweiler JM, Anstice NS, Burakevych N, Chakraborty A, Chase JG, et al. Association of neonatal glycemia with neurodevelopmental outcomes at 4.5 years. JAMA Pediatr. 2017;171:972–83.
McKinlay CJ, Alsweiler JM, Ansell JM, Anstice NS, Chase JG, Gamble GD, et al. Neonatal glycemia and neurodevelopmental outcomes at 2 years. N Engl J Med. 2015;373:1507–18.
Wei X, Franke N, Alsweiler JM, Brown GTL, Gamble GD, McNeill A, et al. Dextrose gel prophylaxis for neonatal hypoglycaemia and neurocognitive function at early school age: a randomised dosage trial. Arch Dis Child Fetal Neonatal Ed. 2024;109:421–7.
Harris DL, Weston PJ, Harding JE. Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr. 2012;161:787–91.
Wight NE, Academy of Breastfeeding Medicine. ABM clinical protocol #1: guidelines for glucose monitoring and treatment of hypoglycemia in term and late preterm neonates, revised 2021. Breastfeed Med. 2021;16:353–65.
Mukhopadhyay S, Wade KC, Dhudasia MB, Skerritt L, Chou JH, Dukhovny D, et al. Clinical impact of neonatal hypoglycemia screening in the well-baby care. J Perinatol. 2020;40:1331–8.
Saginur M, Abdulnour J, Guérin E, Bancroft X, Corsi DJ, Zazzera VD, et al. Association between newborn hypoglycemia screening and breastfeeding success in an Ottawa, Ontario, hospital: a retrospective cohort study. CMAJ Open. 2023;11:E381–88.
LeBlanc S, Haushalter J, Seashore C, Wood KS, Steiner MJ, Sutton AG. A quality-improvement initiative to reduce NICU transfers for neonates at risk for hypoglycemia. Pediatrics. 2018;141:e20171143.
Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. Squire 2.0 (Standards for Quality Improvement Reporting Excellence): revised publication guidelines from a detailed consensus process. Am J Crit Care. 2015;24:466–73.
Provost LP, Murray SK The health care data guide: learning from data for improvement. Jossey-Bass; 2011:xxi
Batra M, Ikeri K, Blake M, Mantell G, Bhat R, Zayek M. Oral dextrose gel for hypoglycemia in a well-baby nursery: a baby-friendly initiative. J Perinatol. 2025;45:1345–51.
Chou JH, Roumiantsev S, Singh R. PediTools electronic growth chart calculators: applications in clinical care, research, and quality improvement. J Med Internet Res. 2020;22:e16204.
Hulse WN, Schulte K, Eickelkamp-Marron V, Redder H, Davidson JM, Chan B, et al. A quality improvement initiative for neonatal hypoglycemia screening and management in a level III neonatal intensive care unit. J Perinatol. 2023;43:1321–9.
Acknowledgements
We thank the nursing staff in the L&D and MBU units at the University of South Alabama Children’s and Women’s Hospital for their valuable contributions to this initiative.
Author information
Authors and Affiliations
Contributions
KI conceptualized and designed the initiative, participated in the development and implementation of all phases of the PDSA cycles, led the statistical analysis, developed the control charts and figures, drafted the initial manuscript and reviewed and revised the final manuscript; VC conceptualized and designed the initiative, participated in the development and implementation of all phases of the PDSA cycles, and reviewed the final manuscript; AB and TE participated in the development and implementation of PDSA cycles, and reviewed the final manuscript; MR participated in the development and implementation of the PDSA cycles, reviewed for critical intellectual content and reviewed the final manuscript; MZ conceptualized the initiative, participated in the development and implementation of the PDSA cycles, developed the tables, reviewed for critical intellectual content and revised the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ikeri, K., Curtis, V., Bozeman, A. et al. Improving timing of early neonatal hypoglycemia screening in the well-baby nursery. J Perinatol 46, 470–475 (2026). https://doi.org/10.1038/s41372-025-02467-y
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41372-025-02467-y


